Assessing the Value of Treatments for Spinal Muscular Atrophy

Assessing the Value of Treatments for Spinal Muscular Atrophy
Special Issue editors: Chris D. Skedgel, Nicole Gusset
PharmacoEconomics, Volume 40, supplement issue 1, April 2022
Editorial

Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain
Chris Skedgel
Published: 22 December 2021

Importance of Patient Involvement in the Value Assessment Process: On the Way Towards Personalised Treatments
Nicole Gusset
Content type: Editorial
Published: 16 December 2021

Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management
Authors (first, second and last of 4): Noman Paracha, Pollyanna Hudson, C. Simone Sutherland
Content type: Systematic Review
Open Access
Published: 11 November 2021

Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers
Authors (first, second and last of 4): C. Simone Sutherland, Pollyanna Hudson, Noman Paracha
Content type: Systematic Review
Open Access
Published: 15 December 2021

Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Authors (first, second and last of 4): Noman Paracha, Pollyanna Hudson, C. Simone Sutherland
Content type: Systematic Review
Open Access
Published: 18 October 2021

Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom
Authors (first, second and last of 6): Siu Hing Lo, Ksenija Gorni, Noman Paracha
Content type: Original Research Article
Open Access
Published: 18 October 2021

Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries
Authors (first, second and last of 5): Siu Hing Lo, Claire Lawrence, Andrew J. Lloyd
Content type: Original Research Article
Open Access
Published: 13 December 2021

Correction to: Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain
Authors: Chris Skedgel
Content type: Correction
Published: 25 February 2022

Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Authors (first, second and last of 4): Noman Paracha, Pollyanna Hudson, C. Simone Sutherland,
Content type: Correction
Open Access
Published: 26 Feb